Rare diseases, like Fabry disease, mean a major health problem for a significant number of people in total, but affecting small number of patients for each individual disease.

Smart4Fabry is a project conceived and created to obtain a new nanoformulation of GLA, that will improve the efficacy and toleration compared to the actual treatment with non-formulated GLA. The final benefit will be seen as considerable reduction on the Fabry disease treatment cost and a substantial improvement in the life-quality of Fabry disease patients.

Join the Smart4Fabry Final Workshop to learn from expert speakers how, why and for what the solution proposed by Smart4Fabry was conceived, a sign of cooperation at European level to boost nanomedicine development and translation to clinical stages.

See you there!


Smart4Fabry is the acronym of a H2020 funded Project
that stands for “Smart functional GLA-nanoformulation
for Fabry disease”. Smart4Fabry is a collaborative project
funded under the H2020 EU Research
and Innovation programme.

The project started on
the 1st January 2017 and will last four years.



Old news


Nothing from 25.1.2021 to 24.3.2021.